Cases & investigations

Cases & investigations

Corvus Pharmaceuticals

Kaskela Law LLC is investigating Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) (“Corvus”) on behalf of the company’s shareholders.

The investigation seeks to determine whether Corvus and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties to the company’s investors in connection with recent corporate actions.

Corvus shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by completing the form on this page, for additional information about this investigation and their legal rights and options.

CONTACT:

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
([email protected])
Adrienne Bell, Esq.
([email protected])
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750

Submit Your Information

  • This field is for validation purposes and should be left unchanged.

Contact Us

  • This field is for validation purposes and should be left unchanged.